Back to results
US 2006/0223869 A1Published application
Compounds for the reduction of excessive food intake
AssigneeBoehringer Ingelheim Pharma GmbH & Co. KG
InventorsMichael PIEPER, Joachim Mierau
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of dopamine receptor agonists for preparing a pharmaceutical composition for the reduction of excessive food intake.
Claims4
A pharmaceutical composition comprising as a first active substance a first dopamine receptor agonist, wherein the first dopamine receptor agonist is a D3 receptor agonist, in combination with a second active substance selected from the group consisting of:
- D1, D2, D3, and D4 receptor agonists, anorectics, lipase inhibitors and sympathomimetics.
Dependencies are inferred from the claim text.